NEW YORK (GenomeWeb News) — IntegraGen today said it has received a €2 million ($2.5 million) equity investment from DSM Venturing, with which it has also signed a research partnership to develop molecular diagnostics.
 
Under the terms of the agreement, IntegraGen will receive upfront fees, licensing fees, and funding to develop gene-based diagnostic and prognostic tests.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.